مقایسه دو سو کور ایمنی و کارآیی لوازیدون و زیپراسیدون در بیماران سرپایی بالینی با اسکیزوفرنی یا اختلال اسکیزوآفرانس

In this double-blind, fixed-dose comparison of lurasidone 120 mg and ziprasidone 160 mg, treatment with lurasidone was well-tolerated and safe, and was not associated with clinically significant changes from baseline in weight, metabolic parameters, or QTc interval. Study limitations include the relatively short trial duration and lack of placebo control.